DK2324111T3 - Yderzone-tumorceller samt fremgangsmåde til fremstilling deraf samt anvendelse deraf - Google Patents
Yderzone-tumorceller samt fremgangsmåde til fremstilling deraf samt anvendelse derafInfo
- Publication number
- DK2324111T3 DK2324111T3 DK09778433.4T DK09778433T DK2324111T3 DK 2324111 T3 DK2324111 T3 DK 2324111T3 DK 09778433 T DK09778433 T DK 09778433T DK 2324111 T3 DK2324111 T3 DK 2324111T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- well
- tumor cells
- outer zone
- zone tumor
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0693—Tumour cells; Cancer cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19164008P | 2008-09-10 | 2008-09-10 | |
| PCT/EP2009/006547 WO2010028820A2 (en) | 2008-09-10 | 2009-09-09 | Peripheral zone tumor cells, methods for their preparation and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2324111T3 true DK2324111T3 (da) | 2013-09-30 |
Family
ID=41398932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09778433.4T DK2324111T3 (da) | 2008-09-10 | 2009-09-09 | Yderzone-tumorceller samt fremgangsmåde til fremstilling deraf samt anvendelse deraf |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US9103819B2 (da) |
| EP (1) | EP2324111B1 (da) |
| AU (1) | AU2009291203B2 (da) |
| DK (1) | DK2324111T3 (da) |
| WO (1) | WO2010028820A2 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2437159C1 (ru) * | 2010-04-26 | 2011-12-20 | Государственное общеобразовательное учреждение высшего профессионального образования "Российский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО РГМУ Росздрава) | Способ визуализации астроглиального вала в диагностике низкодифференцированных глиом |
| ES2537403T3 (es) | 2010-07-27 | 2015-06-08 | Genomic Health, Inc. | Método para usar la expresión génica para determinar el pronóstico de cáncer de próstata |
| FR2964744B1 (fr) * | 2010-09-10 | 2015-04-03 | Univ Versailles St Quentin En Yvelines | Test pronostic de l'evolution d'une tumeur solide par analyse d'images |
| EP2784510A1 (en) * | 2013-03-25 | 2014-10-01 | Universität Zu Köln | Methods of diagnosing and differentiating oncocytoma and malignant renal carcinoma as well as products and uses relating thereto |
| EP4378531A3 (en) | 2017-03-09 | 2024-09-04 | Thomas Jefferson University | Methods and compositions for treating cancers using antisense |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040072345A1 (en) * | 1997-06-20 | 2004-04-15 | Altaba Ariel Ruiz I. | Method and compositions for inhibiting tumorigenesis |
| US5891432A (en) * | 1997-07-29 | 1999-04-06 | The Immune Response Corporation | Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same |
| CA2447400A1 (en) * | 2003-09-12 | 2005-03-12 | The Hospital For Sick Children | Brain tumor stem cells |
| US20070037224A1 (en) * | 2005-08-11 | 2007-02-15 | Hamer Peter J | Quantitative assays for PDGFR-beta in body fluids |
| WO2007062138A2 (en) * | 2005-11-23 | 2007-05-31 | Applera Corporation | Methods and compositions for treating diseases targeting human prominin-1(cd133) |
| WO2007134274A2 (en) | 2006-05-12 | 2007-11-22 | Attenuon, Llc | Antibodies to urokinase- type plasminogen activator receptor(upar)bind cancer stem cells: use in diagnosis and therapy |
| WO2008033393A2 (en) * | 2006-09-11 | 2008-03-20 | University Of Florida | Isolation, expansion and uses of tumor stem cells |
| DK2328923T3 (da) * | 2008-09-02 | 2016-03-21 | Cedars Sinai Medical Center | Cd133-epitoper |
-
2009
- 2009-09-09 DK DK09778433.4T patent/DK2324111T3/da active
- 2009-09-09 AU AU2009291203A patent/AU2009291203B2/en not_active Ceased
- 2009-09-09 EP EP09778433.4A patent/EP2324111B1/en active Active
- 2009-09-09 WO PCT/EP2009/006547 patent/WO2010028820A2/en not_active Ceased
- 2009-09-09 US US12/867,442 patent/US9103819B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2324111B1 (en) | 2013-07-03 |
| WO2010028820A2 (en) | 2010-03-18 |
| WO2010028820A3 (en) | 2010-06-17 |
| AU2009291203A1 (en) | 2010-03-18 |
| AU2009291203B2 (en) | 2015-01-22 |
| EP2324111A2 (en) | 2011-05-25 |
| US9103819B2 (en) | 2015-08-11 |
| US20110052642A1 (en) | 2011-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3130923T3 (da) | Terapeutiske fremgangsmåder i forbindelse med cancerstamceller | |
| IL252119B (en) | Improved cell composition and methods of making the same | |
| PT2577318T (pt) | Método de diferenciação de nocicetor de células estaminais embrionárias humanas e utilizações do mesmo | |
| BRPI0909367A2 (pt) | calçado e método de fabricação do mesmo | |
| DK2761126T3 (da) | Wellbore stimulation assemblies and methods of using the same | |
| GB201013989D0 (en) | Biological materials and methods of using the same | |
| SMT201600050B (it) | Mezzi e metodi per trattare il dlbcl | |
| BR112013007499A2 (pt) | piridazinonas - métodos de criação e usos | |
| PL2358756T3 (pl) | Ludzkie przeciwciała o wysokim powinowactwie wobec pcsk9 | |
| DK2526254T3 (da) | Wellbore knock-out chamber and related methods of use | |
| EP2714970A4 (en) | Enzyme QUANTIFICATION | |
| PL2657253T3 (pl) | Przeciwciała anty-CD79b i immunokoniugaty i sposoby stosowania | |
| PL2552959T3 (pl) | Przeciwciała przeciwko MUC16 i metody stosowania | |
| PL2506850T3 (pl) | Sposoby podawania terapii pirfenidonem | |
| HRP20160169T1 (xx) | Uäśinkovita hidoliza lignoceluloze s integriranom proizvodnjom enzima | |
| EP2367866A4 (en) | POLYESTER, MANUFACTURING METHOD THEREFOR AND USE | |
| EP2761016A4 (en) | REDOX REAGENT COMPOSITION FOR ELECTROCHEMICAL BIOSENSOR AND BIOSENSOR CONTAINING THE SAME | |
| IL236182A0 (en) | Methods for detecting diseases or conditions using circulating diseased cells | |
| SMT201600332B (it) | Composizioni e metodi per l’aumento dell’attivitàtelomerasica | |
| EP2242854A4 (en) | COMPOUNDS AND USES THEREOF | |
| KR100977015B9 (ko) | 콘크리트 부유체 및 이를 이용한 부유조립체 | |
| BRPI0917684A2 (pt) | método terapêutico homeopático | |
| BR112013011232A2 (pt) | batom e outros cosméticos e método de produção | |
| DK2324111T3 (da) | Yderzone-tumorceller samt fremgangsmåde til fremstilling deraf samt anvendelse deraf | |
| BRPI1010684A2 (pt) | método para determinar o potencial cardiorregenerativo de células mamíferas |